fda category 2 bulk drug substances bpc-157 compounding list Peptide Therapy in Austin, TX Pharmacy Purchasing & Products Magazine
Pharmacy Purchasing & Products Magazine This just in: The FDA is proposing to move 14 commonly used peptides from Category 2 to Category 1 on the compounding review list If finalized, this shift could significantly change FDA advisers back first four of seven unapproved peptides under review for looser rules Reuters What Peptides Are Becoming Legal in 2026?
Pay in 4 interest-free payments of $6.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17


